EFDID: 584011EFD: View Filing

Issuer: ClearPoint Neuro, Inc. (0001285550) - D

Accession: 0001683168-26-000772 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001285550
  • Entity Name:
    ClearPoint Neuro, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    120 S. SIERRA AVENUE
    SUITE 100
    SOLANA BEACH, CA 92075
  • Persons:
    Related Persons 11
    Joseph M. Burnett
    Executive Officer, Director
    R. John Fletcher
    Director
    Lynnette C. Fallon
    Director
    Pascal E.R. Girin
    Director
    B. Kristine Johnson
    Director
    Matthew B. Klein
    Director
    Linda M. Liau
    Director
    Timothy T. Richards
    Director
    Danilo D'Alessandro
    Executive Officer
    Jeremy L. Stigall
    Executive Officer
    Mazin Sabra
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    02/05/2026
  • First Sale Date:
    11/20/2025
  • Offering Amount:
    $17,892,698
  • Amount Sold:
    $17,892,698
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    Calculated based on closing price of common stock on closing date of merger. Includes up to 205,000 shares of common stock that may be cancelled to satisfy obligations of former equityholders of IRRAS Holdings, Inc. under merger agreement.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
ClearPoint Neuro, Inc./s/ Danilo D'AlessandroDanilo D'AlessandroChief Financial Officer2026-02-05